FAT-regulated gene expression after tacrolimus

Phase 1

• Conditions: Immunosuppression after liver transplantation; MedDRA version: 20.1Level: PTClassification code 10062016Term: ImmunosuppressionSystem Organ Class: 10021428 - Immune system disorders; MedDRA version: 21.0Level: LLTClassification code 10024716Term: Liver transplantationSystem Organ Class: 100000004865; Therapeutic area: Body processes [G] - Immune system processes [G12]

• Registration Number: EUCTR2018-001290-24-AT
• Lead Sponsor: Medical University of Graz

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-11-27
• Last Update Posted: 21 December 2021

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

-Patients >= 18 years of age
-Liver transplantation
-Informed consent

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 27
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 8

Exclusion Criteria

-Patients < 18 years
-Patients taking actively part in a different interventional Trial

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified